Page last updated: 2024-08-01 17:18:34

cinnamoyl chloride

Description

cinnamoyl chloride: RN given refers to cpd without isomeric designation [MeSH]

Cross-References

ID SourceID
PubMed CID5354261
SCHEMBL ID37935
MeSH IDM0113554

Synonyms (59)

Synonym
unii-04l46s032w
04l46s032w ,
2-propenoyl chloride, 3-phenyl-, (e)-
LS-13582
(e)-3-phenyl-acryloyl chloride
.beta.-phenylacryloyl chloride
102-92-1
nsc-4683
2-propenoyl chloride, 3-phenyl-
cinnamic chloride
cinnamoylchloride
cinnamic acid chloride
cinnamoyl chloride
nsc4683
3-phenyl-2-propenoyl chloride
cinnamoyl chloride, 98%
3-phenylprop-2-enoyl chloride
(e)-3-phenylprop-2-enoyl chloride
17082-09-6
P0133
trans-3-phenylacryloyl chloride
AKOS000121270
A800646
(e)-3-phenyl-2-propenoyl chloride
nsc 4683
einecs 203-065-5
beta-phenylacryloyl chloride
BBL011393
(2e)-3-phenylprop-2-enoyl chloride
STL146496
trans-cinnamoyl chloride
AM20060479
phenylacryloylchloride
[(2e)-3-phenylprop-2-enoyl]chloride
trans-cinnamoylchloride
(2e)-3-phenylacryloyl chloride
SCHEMBL37935
benzylideneacetyl chloride
cinnamoyl chloride [mi]
trans-cinnamic acid chloride
(e)-cinnamoyl chloride
2-propenoyl chloride, 3-phenyl-, (2e)-
3-phenylacryloyl chloride
Q-200858
F2190-0089
CS-0006860
6-[bis[bis(isopropyl)amino]acetate]-d-gluconicacid
Q204169
3-amino-4-morpholin-4-yl-benzoicacidethylester
3L-308S
mfcd00000732
D91905
trans-3-phenylacryloyl chlorid
trans-cinnamoyl chloride,97%
A881990
DTXSID401312860
2-propenoyl chloride,3-phenyl-, (2e)-
EN300-19598
EN300-248477

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (22.22)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (66.67)24.3611
2020's1 (11.11)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (100.00%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
quinacrineacridines;
aromatic ether;
organochlorine compound;
tertiary amino compound
antimalarial;
EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor
201520159.0low000010
chlorinehalide anion;
monoatomic chlorine
cofactor;
Escherichia coli metabolite;
human metabolite
201520159.0low000010
2-butynedioic acidacetylenic compound;
C4-dicarboxylic acid
2012201212.0medium000010
1-propanolpropan-1-ols;
short-chain primary fatty alcohol
metabolite;
protic solvent
1983198341.0low020000
1-methylimidazoleimidazoles1983198341.0low020000
4-aminopyridineaminopyridine;
aromatic amine
avicide;
orphan drug;
potassium channel blocker
1983198341.0low020000
chloroquineaminoquinoline;
organochlorine compound;
secondary amino compound;
tertiary amino compound
anticoronaviral agent;
antimalarial;
antirheumatic drug;
autophagy inhibitor;
dermatologic drug
201520159.0low000010
cyanidespseudohalide anionEC 1.9.3.1 (cytochrome c oxidase) inhibitor2012201212.0low000010
benzoyl chlorideacyl chloride;
benzenes
carcinogenic agent2012201212.0low000010
propylenealkene;
gas molecular entity
refrigerant;
xenobiotic
2012201212.0low000010
alpha-aminopyridine1983198341.0low020000
4-dimethylaminopyridinedialkylarylamine;
tertiary amino compound
1983198341.0medium020000
alkenes2012201212.0low000010
glucose, (beta-d)-isomerD-glucopyranoseepitope;
mouse metabolite
2013201311.0low000010
2-vinylfuran2012201212.0medium000010
glycosides2013201311.0low000010
cinnamic anhydride1983198341.0high020000
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Acute Confusional Senile Dementia0202020204.0high000010
Alzheimer Disease0202020204.0high000010
Idiopathic Parkinson Disease0202020204.0high000010
Parkinson Disease0202020204.0high000010